Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2015

Open Access 01-12-2015 | Research Article

Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia

Authors: Sarah Acaster, Rene Dickerhoof, Kendra DeBusk, Kristine Bernard, William Strauss, Lee F. Allen

Published in: Health and Quality of Life Outcomes | Issue 1/2015

Login to get access

Abstract

Background

Fatigue is a burdensome symptom in iron deficiency anemia (IDA). To capture the severity and impact of fatigue appropriately it must be measured using validated scales. This study evaluated the content validity and psychometric validity of the Functional Assessment of Chronic Illness Therapy - fatigue scale (FACIT-fatigue) in IDA patients.

Methods

Qualitative patient interviews were conducted in the United States to evaluate content validity. The psychometric properties of the FACIT-fatigue scale were investigated using data from a phase 3 clinical trial assessing ferumoxytol in patients with a history of unsatisfactory oral iron therapy or in whom oral iron cannot be used. The statistical analysis assessed the acceptability, reliability, validity and responsiveness of the FACIT-fatigue scale.

Results

Qualitative interviews showed that fatigue is a central concern to IDA patients and that the FACIT-fatigue scale sufficiently assessed this construct. Psychometric assessment demonstrated that the FACIT-fatigue scale was stable over time (ICC = 0.87) and internally consistent (α = 0.93). The scale demonstrated convergence with other conceptually relevant scales such as SF-36 Vitality (r = 0.74), and distinguished between known groups [i.e., treatment arms (mean difference (95 % CI) = 3.56 (1.68, 5.43), p <0.001) and high vs. low hemoglobin groups (mean difference (95 % CI) = 5.51 (8.59, 2.44) p <0.001)]. Responsiveness was also demonstrated; significant improvements in FACIT-fatigue scale scores corresponded with significant differences between minimal, moderate, and much improved vitality cohorts (p < 0.05).

Conclusions

This research demonstrated that the FACIT-fatigue scale has sound measurement properties and is an appropriate and interpretable assessment of fatigue among IDA patients with various underlying conditions.
Literature
1.
Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75:671–8.PubMed
2.
Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277:973–6.CrossRefPubMed
3.
Cavill I, Auerbach M, Bailie GR, Barrett-Lee P, Beguin Y, Kaltwasser P, et al. Iron and the anaemia of chronic disease: a review and strategic recommendations. Curr Med Res Opin. 2006;22:731–7.CrossRefPubMed
4.
World Health Organization. Prevalence of Anemia in Women. 1992.
5.
6.
Rosenzweig PH, Volpe SL. Iron, thermoregulation and metabolic rate. Crit Rev Food Sci Nutr. 1999;39:131–48.CrossRefPubMed
7.
Miller JF. Iron deficiency anemia: a common and curable disease. Cold Spring Harb Perspect Med. 2013;3:1–13.CrossRef
8.
Cella D, Kallich J, McDermott A, Xu X. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol. 2004;15:979–86.CrossRefPubMed
9.
Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer. 2002;86:1243–9.CrossRefPubMedCentralPubMed
10.
Jacobsen PB, Garland LL, Booth-Jones M, Donovan KA, Thors CL, Winters E, et al. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manage. 2004;28:7–18.CrossRefPubMed
11.
Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;15:528–38.CrossRef
12.
Yellen SB, Cella D, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74.CrossRefPubMed
13.
Kosinski M, Gajria K, Fernandes AW, Cella D. Qualitative validation of the FACIT-Fatigue scale in systemic lupus erythematosus. Lupus. 2013;22:422–30.CrossRefPubMed
14.
Lai JS, Beaumont JL, Ogale S, Brunetta P, Cella D. Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol. 2011;38:672–9.CrossRefPubMed
15.
Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811–9.PubMed
16.
Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis. 2007;66:936–9.CrossRefPubMedCentralPubMed
17.
Signorovitch J, Brainsky A, Grotzinger KM. Validation of the FACIT-Fatigue subscale, selected items from FACT-thrombocytopenia, and the SF36v2 in patients with chronic immune thrombocytopenia. Qual Life Res. 2011;20:1737–44.CrossRefPubMed
18.
Hagell P, Hoglund A, Reimer J, Eriksson B, Knutsson I, Widner H, et al. Measuring fatigue in Parkinson’s disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manage. 2006;32:420–32.CrossRefPubMed
19.
U.S. Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009.
20.
Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD. Use of Existing Patient-reported Outcome (PRO) Instruments and their modification: The ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report. Value Health. 2009;12:1075–83.CrossRefPubMed
21.
Vadhan-Raj S, Strauss W, Ford D, Bernard K, Boccia R, Li J, et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol. 2014;89:7–12.CrossRefPubMedCentralPubMed
22.
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
23.
Patrick DL, Gagnon DD, Zagari MJ, Mathijs R, Sweetenham J, Epoetin Alfa Study Group. Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. Eur J Cancer. 2003;39:335–45.CrossRefPubMed
24.
McHorney CA, Ware Jr JE, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–63.CrossRefPubMed
25.
26.
Joffe H, Yardley L. Content and thematic analysis. In: Marks D, Yardley L, editors. Research Methods for Clinical and Health Psychology. London: Sage; 2004. p. 56–68.
27.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
28.
Willis GB. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks, California: Sage; 2005.
29.
30.
Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10:269–81.CrossRefPubMed
31.
McHorney CA, Tarlov AR. Individual patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4:293–307.CrossRefPubMed
32.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334.CrossRef
33.
Nunnally J. Psychometric Theory. New York, NY: McGraw-Hill; 1978.
34.
Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205.CrossRef
35.
Kline P. A handbook of test construction: introduction to psychometric design. New York, NY: Methuen; 1986.
36.
Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York, NY: McGraw-Hill; 1994.
37.
Wyrwich K, Norquist J, Lenderking W, Acaster S. Methods for interpreting change over time in patient-reported outcome measures. Qual Life Res. 2013;22:475–83.CrossRefPubMed
38.
Acaster S, Swinburn P, Wang C, Stemper B, Beckmann K, Knappertz V. et.al.: Can the Functional Assessment of Multiple Sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis. Multiple Sclerosis Journal; 2011;17:1504-1513.
39.
Lloyd AJ, Loftus J, Turner M, Lai G, Pleil A. Psychometric validation of the visual function questionnaire-25 in patients with diabetic macular edema. Health Qual Life Outcomes. 2013;11:10–21.CrossRefPubMedCentralPubMed
40.
Prins MH, Guillemin I, Gilet H, Gabriel S, Essers B, Raskob G, et al. Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q). Health Qual Life Outcomes. 2009;7:30–42.CrossRefPubMedCentralPubMed
Metadata
Title
Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia
Authors
Sarah Acaster
Rene Dickerhoof
Kendra DeBusk
Kristine Bernard
William Strauss
Lee F. Allen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2015
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-015-0257-x

Other articles of this Issue 1/2015

Health and Quality of Life Outcomes 1/2015 Go to the issue

Research

A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease

Research

Interpreting small treatment differences from quality of life data in cancer trials: an alternative measure of treatment benefit and effect size for the EORTC-QLQ-C30

Research

Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches

Research

Fatigue in Egyptian patients with rheumatic diseases: a qualitative study

Research

Oral health-related quality of life and related factors among residents in a disaster area of the Great East Japan Earthquake and giant tsunami

Research

Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool